Authors: Chillik, C Young, E Gogorza, S Estofan, D Neuspiller, N Antunes, N Borges, E Petracco, A Vantman, D Fabres, C Montoya, JM Madero, JI Gutierrez-Najar, A Bronfenmajer, S Kovac's, A Kroeze, S Out, HJ

Citation: C. Chillik et al., A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitrofertilization, FERT STERIL, 76(5), 2001, pp. 950-956